AN2 Therapeutics Revenue and Competitors

Location

#4780

Growjo Ranking

Biotech

Industry

Estimated Revenue & Valuation

  • AN2 Therapeutics's estimated annual revenue is currently $7.9M per year.(i)
  • AN2 Therapeutics's estimated revenue per employee is $155,000

Employee Data

  • AN2 Therapeutics has 51 Employees.(i)
  • AN2 Therapeutics grew their employee count by 6% last year.

AN2 Therapeutics's People

NameTitleEmail/Phone
1
CSOReveal Email/Phone
2
CEO & Co-FounderReveal Email/Phone
3
CFOReveal Email/Phone
4
VP ChemistryReveal Email/Phone
5
SVP Clinical DevelopmentReveal Email/Phone
6
SVP Regulatory Affairs & Quality AssuranceReveal Email/Phone
7
VP, CMCReveal Email/Phone
8
VP, BiostatisticsReveal Email/Phone
9
VP Finance and Corporate ControllerReveal Email/Phone
10
VP Quality AssuranceReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.4M57-8%$53MN/A
#2
$21.2M137-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.3M1515%N/AN/A
#5
$1.6M10-17%N/AN/A
#6
$0.7M950%N/AN/A
#7
$11.5M74-12%N/AN/A
#8
$0.4M27510%$236.7MN/A
#9
$4M51-74%$160MN/A
#10
$2.3M1515%N/AN/A
Add Company

What Is AN2 Therapeutics?

AN2 Therapeutics, Inc. is a California-based global health biopharmaceutical company focused on bringing the power of modern biomedical and drug development expertise to provide transformational medicines for patients suffering from infectious diseases. AN2 is a mission-driven company, with a vision for humanity to be free from the threat of infectious diseases by addressing the urgent need for new treatments that can save lives across the globe. Founded by a small team of biopharmaceutical industry leaders with a passion for global health and experience in infectious disease drug R&D, we strive to bring patients treatments that will restore their health and enable them to live productive lives.

keywords:N/A

N/A

Total Funding

51

Number of Employees

$7.9M

Revenue (est)

6%

Employee Growth %

N/A

Valuation

N/A

Accelerator

AN2 Therapeutics News

2022-03-22 - Bay Area's first stock debut in nearly 2 months, by AN2 ...

AN2 Therapeutics Inc. on Thursday broke a nearly two-month ... AN2 enters its first day of trading Friday (NASDAQ:ANTX) with a market cap of...

2022-03-22 - AN2 upsizes IPO, teeing up bid to revitalize antibiotic let go by ...

AN2 Therapeutics has found public investors willing to bet on biotech, enabling it to upsize its IPO and reel in $69 million for a pivotal trial of an...

2022-03-22 - AN2 Therapeutics' IPO raises $69M to take antibiotic from ...

AN2 is developing an antibiotic based on boron chemistry that could offer advantages over carbon-based molecules. The biotech plans to advance...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$4M5138%$18M
#2
$9.8M52-7%N/A
#3
$7.5M5347%N/A
#4
$6.5M53-2%$8.9M
#5
$16M554%N/A